S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David C. Seldin, MD, PhD
Boston Medical Center
Study Chair - Vaishali Sanchorawala, MD
Boston Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Mountain States Tumor Institute at St. Luke'S Regional Medical Center
Boise, Idaho, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Tammy Walker Cancer Center at Salina Regional Health Center
Salina, Kansas, United States
- Boston University Cancer Research Center
Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan, United States
- Billings Clinic - Downtown
Billings, Montana, United States
- Ccop - Montana Cancer Consortium
Billings, Montana, United States
- Hematology-Oncology Centers of the Northern Rockies - Billings
Billings, Montana, United States
- Northern Rockies Radiation Oncology Center
Billings, Montana, United States
- Bozeman Deaconess Cancer Center
Bozeman, Montana, United States
- St. James Healthcare Cancer Care
Butte, Montana, United States
- Big Sky Oncology
Great Falls, Montana, United States
- Great Falls Clinic - Main Facility
Great Falls, Montana, United States
- Sletten Cancer Institute at Benefis Healthcare
Great Falls, Montana, United States
- Facility name not stated
Great Falls, Montana, United States
- Northern Montana Hospital
Havre, Montana, United States
- St. Peter'S Hospital
Helena, Montana, United States
- Glacier Oncology, Pllc
Kalispell, Montana, United States
- Kalispell Medical Oncology at Krmc
Kalispell, Montana, United States
- Guardian Oncology and Center for Wellness
Missoula, Montana, United States
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
Missoula, Montana, United States
- Montana Cancer Specialists at Montana Cancer Center
Missoula, Montana, United States
- James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Legacy Good Samaritan Hospital & Comprehensive Cancer Center
Portland, Oregon, United States
- Northwest Cancer Specialists at Rose Quarter Cancer Center
Portland, Oregon, United States
- Thompson Cancer Survival Center
Knoxville, Tennessee, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
Seattle, Washington, United States
- University Cancer Center at University of Washington Medical Center
Seattle, Washington, United States
- Rocky Mountain Oncology
Casper, Wyoming, United States
- Welch Cancer Center at Sheridan Memorial Hospital
Sheridan, Wyoming, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2004
- Primary completion
- 31 May 2012
- Completion
- 30 Nov 2015
- Last update posted
- 9 Aug 2018
- Registered enrollment
- 104
- Registry id
- NCT00064337
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.